Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets
(Adnkronos) – VIENNA, May 11, 2023 /PRNewswire/ — Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company’s botulinum toxin product, in 12 additional European markets. These
